(NP (NP (NP (JJ Molecular) (NNS mechanisms)) (PP (IN of) (NP (NN steroid) (NN action))) (: :)) (NP (NP (DT a) (JJ novel) (NN type)) (PP (IN of) (NP (NP (NN cross-talk)) (PP (IN between) (NP-COOD (NP (NNS glucocorticoids)) (CC and) (NP (NN NF-kappa) (NN B) (NN transcription) (NNS factors)))))) (. .)))
(S (PP (IN Despite) (NP (NP (DT the) (JJ widespread) (NN use)) (PP (IN of) (NP (NNS glucocorticoids))) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NP (NNS diseases)) (VP (VBN characterized) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NN inflammation)))))))))) (, ,) (NP-SBJ-29 (NP (DT the) (JJ molecular) (NN mechanism) (-LRB- -LRB-) (NNS s) (-RRB- -RRB-)) (SBAR (WHPP-30 (IN by) (WHNP (WDT which))) (S (NP-SBJ (DT these) (NNS hormones)) (VP (VBP exert) (NP (DT this) (JJ beneficial) (NN effect)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NN asthma))))) (PP (-NONE- *T*-30)))))) (VP (VBZ remains) (S (NP-SBJ-31 (-NONE- *-29)) (VP (TO to) (VP (VB be) (VP (VBN elucidated) (NP (-NONE- *-31))))))) (. .))
(S (ADVP (RB Therefore)) (, ,) (NP-SBJ (PRP we)) (VP (VBP have) (VP (VBN studied) (NP (NP (DT the) (JJ transcriptional) (NN regulation)) (PP (IN of) (NP (NP (JJ intercellular) (NN adhesion) (NN molecule-1)) (PRN (-LRB- -LRB-) (NP (NN ICAM-1)) (-RRB- -RRB-))))) (SBAR (IN as) (S (NP-SBJ-32 (NN adhesion) (NNS molecules)) (VP (VBP are) (ADJP-PRD (JJ likely) (S (NP-SBJ-33 (-NONE- *-32)) (VP (TO to) (VP (VB play) (NP (DT a) (JJ causal) (NN role)) (PP (IN in) (NP (NN inflammation))) (PP (IN in) (S (NP-SBJ (-NONE- *-33)) (VP (VBG promoting) (NP (ADJP-COOD (ADJP (JJ cell-cell)) (CC and) (ADJP (JJ cell-matrix))) (NNS interactions)))))))))))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBD observed) (SBAR (IN that) (S (PP (IN in) (NP (NP-COOD (NP (DT a) (ADJP (ADJP (JJ monocytic)) (PRN (-LRB- -LRB-) (NP (NN U937)) (-RRB- -RRB-))) (NP (-NONE- *RNR*-34))) (CC and) (NP (DT a) (ADJP (ADJP (JJ bronchial) (NN epithelial)) (PRN (-LRB- -LRB-) (NP (NN H292)) (-RRB- -RRB-)) (NP (-NONE- *RNR*-34))))) (NP-34 (JJ cell-line)))) (NP-SBJ (NN dexamethasone)) (ADVP (RB strongly)) (VP (VBD suppressed) (NP (ADJP-COOD (ADJP (JJ basal)) (CC and) (ADJP (VBN induced))) (NN ICAM-1) (NN expression)))))) (. .))
(S (NP-SBJ (NP (JJ Subsequent) (NN analysis)) (PP (IN of) (NP (DT the) (JJ human) (NN ICAM-1) (NN promoter)))) (VP (VBZ has) (VP (VBN revealed) (SBAR (IN that) (S (NP-SBJ-COOD (CC both) (NP (NP (NN 12-O-tetradecanoylphorbol) (NN 13-acetate)) (PRN (-LRB- -LRB-) (NP (NN TPA)) (-RRB- -RRB-))) (CC and) (NP (NP (NN tumour) (NN necrosis) (NN factor-alpha)) (PRN (-LRB- -LRB-) (NP (NN TNF-alpha)) (-RRB- -RRB-)))) (VP (VBP upregulate) (NP (NN ICAM-1) (NN expression)) (PP (IN through) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (DT a) (NP (NP (JJ nuclear) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN NF-kappa) (NN B)) (-RRB- -RRB-))) (NN target) (NN sequence)) (PRN (-LRB- -LRB-) (NP (NN TGGAAATTCC)) (-RRB- -RRB-))))))))))) (. .))
(S-COOD (S (NP-SBJ (DT No) (NN glucocorticoid) (NN recognition) (NNS sequences)) (VP (VBP are) (ADJP-PRD (JJ present) (PP (IN in) (NP (DT this) (NN promoter) (NN region)))))) (CC and) (S (NP-SBJ-35 (NN dexamethasone)) (VP (VBZ is) (ADVP (RB still)) (ADJP-PRD (JJ able) (S (NP-SBJ (-NONE- *-35)) (VP (TO to) (VP (VB repress) (NP (NN transcription)))))) (SBAR-TMP (WHADVP-36 (WRB when)) (S (NP-SBJ-37 (DT the) (JJ multimerized) (NN NF-kappa) (NN B) (NN sequence)) (VP (VBZ is) (VP (VBN transactivated) (NP (-NONE- *-37)) (PP (IN by) (NP (NN TNF-alpha))) (PP-TMP (IN upon) (NP (NP (NN transfection)) (PP (IN in) (NP (CD 293) (NNS cells))))) (ADVP (-NONE- *T*-36)))))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBP propose) (SBAR (IN that) (S (NP-SBJ (NP (JJ direct) (NN interaction)) (PP (IN between) (NP-COOD (NP (DT the) (NN glucocorticoid) (NN receptor)) (CC and) (NP (JJ nuclear) (NN factor-kappa) (NN B) (NNS factors))))) (VP (VBZ is) (ADVP (IN at) (JJS least)) (NP-PRD (NP (DT a) (JJ partial) (NN explanation)) (PP (IN for) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (DT this) (NN hormone))) (PP (IN in) (NP (JJ inflammatory) (NNS diseases)))))))))) (. .))
